RESEARCHER PROFILE
Ruud Delwel
R
Oncode Institute
Ruud Delwel works in Acute Myeloid Leukemia Research, Retinoids in leukemia and cellular processes, Chromatin Remodeling and Cancer, Epigenetics and DNA Methylation, Hematopoietic Stem Cell Transplantation. Recorded institutional associations include Oncode Institute, Erasmus MC Cancer Institute.
330Publications
20,676Citations
67H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
2010 · 2,756 citationsInhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
2011 · 1,503 citationsPrognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
2004 · 1,372 citationsDNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
2010 · 833 citationsA Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia
2014 · 684 citationsMutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance
2005 · 618 citationsDouble CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
2009 · 566 citationsDistinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
2016 · 387 citationsPrognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity
2010 · 384 citationsThe Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation
2013 · 326 citationsBase-Pair Resolution DNA Methylation Sequencing Reveals Profoundly Divergent Epigenetic Landscapes in Acute Myeloid Leukemia
2012 · 295 citationsEpigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia
2015 · 292 citationsHigh EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated
2008 · 280 citationsPharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia
2015 · 277 citationsTherapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation
2019 · 270 citationsMutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
2012 · 262 citationsHigh EVI1 Expression Predicts Outcome in Younger Adult Patients With Acute Myeloid Leukemia and Is Associated With Distinct Cytogenetic Abnormalities
2010 · 256 citationsClinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid Leukemia
2010 · 256 citationsTribbles homolog 2 inactivates C/EBPα and causes acute myelogenous leukemia
2006 · 238 citationsBiallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML
2003 · 235 citationsErratum: Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia
2015 · 207 citationsIdentification of a 24-Gene Prognostic Signature That Improves the European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: An International Collaborative Study
2013 · 206 citationsDistinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1
2007 · 199 citationsSubtype-specific regulatory network rewiring in acute myeloid leukemia
2018 · 185 citationsEssential role of Jun family transcription factors in PU.1 knockdown–induced leukemic stem cells
2006 · 183 citations
